McKool Smith Principal Nick Matich provided commentary to Managing IP's article, "Radical Change or Hot Air? Experts Debate Biden’s ‘March-In’ Plans." The article discusses "the Biden administration has published draft guidance that could let the government override exclusive patent licenses where drug prices are deemed too high." Click here to read the article. 


Jump to Page